Influenza A Infections Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Influenza A Infections Market is segmented By Therapeutic Product (Prophylactic treatments, Antiviral drugs), By Emerging Therapy (mRNA vaccines, Investigational therapies), By Vaccine (High-dose vaccines, Intranasal vaccines), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD Million) for the above-mentioned segments.
Influenza A Infections Market Size
Market Size in USD
CAGR2.7%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 2.7% |
| Market Concentration | Medium |
| Major Players | Cidara Therapeutics, SAb Biotherapeutics, FluGen, Moderna, Vir Biotechnology |
please let us know !
Influenza A Infections Market Analysis
The influenza A infections market is estimated to be valued at USD 723.2 Mn in 2024 and is expected to reach USD 873.4 Mn by 2031, growing at a compound annual growth rate (CAGR) of 2.7% from 2024 to 2031. Widespread initiatives by governments and private organizations to increase vaccination rates along with rising awareness about preventive healthcare have contributed to the market growth.